Gain Therapeutics
GANX
Gain Therapeutics (GANX) earnings history
Most recent quarter
- Fiscal period
- Q2 2025
- Period end
- Jun 30, 2025
- EPS actual
- −$0.19
- EPS estimate
- −$0.17
- EPS surprise
- −13.98%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Aug 12, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2025 | Aug 12, 2025 | −$0.17 | −$0.19 | −13.98% | $0.00 | SEC |
| Q1 2025 | May 14, 2025 | −$0.18 | −$0.16 | +11.01% | $0.00 | SEC |
| Q4 2024 | Mar 27, 2025 | −$0.18 | −$0.08 | +56.45% | $0.00 | SEC |
| Q3 2024 | Nov 14, 2024 | −$0.21 | −$0.17 | +17.95% | $0.00 | SEC |
| Q2 2024 | Aug 8, 2024 | −$0.19 | −$0.42 | −115.61% | $0.00 | SEC |
| Q1 2024 | May 14, 2024 | −$0.31 | −$0.22 | +29.21% | $0.00 | SEC |
| Q4 2023 | Mar 26, 2024 | −$0.31 | −$0.29 | +7.05% | $0.00 | SEC |
| Q3 2023 | Nov 14, 2023 | −$0.45 | −$0.37 | +17.04% | $0.00 | SEC |
| Q2 2023 | Aug 10, 2023 | −$0.31 | −$0.62 | −101.36% | $0.00 | SEC |
| Q1 2023 | May 12, 2023 | −$0.39 | −$0.43 | −9.14% | $55,180.00 | SEC |
| Q4 2022 | Mar 23, 2023 | −$0.36 | −$0.39 | −6.91% | $0.00 | SEC |
| Q3 2022 | Nov 10, 2022 | −$0.45 | −$0.38 | +15.08% | $0.00 | SEC |
| Q2 2022 | Aug 8, 2022 | −$0.30 | −$0.43 | −42.15% | $95,102.00 | SEC |
| Q1 2022 | May 16, 2022 | −$0.35 | −$0.28 | +19.49% | $45,006.00 | SEC |
| Q4 2021 | Mar 24, 2022 | −$0.48 | −$0.27 | +44.11% | $43,000.00 | SEC |
| Q3 2021 | Nov 12, 2021 | −$0.36 | −$0.39 | −9.83% | $27,345.00 | SEC |
| Q2 2021 | Aug 11, 2021 | −$0.27 | −$0.30 | −12.95% | $89,173.00 | SEC |
| Q1 2021 | May 10, 2021 | −$0.32 | −$0.31 | +2.12% | $5,300.00 | SEC |
Quarterly revenue
Frequently asked questions
When did Gain Therapeutics (GANX) last report earnings?
Gain Therapeutics last reported on Aug 12, 2025, covering fiscal Q2 2025.
Did GANX beat earnings estimates?
No. Gain Therapeutics reported EPS of −$0.19 for Q2 2025 against a −$0.17 estimate — a 13.98% miss.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.